Immune Design Corp. (IMDZ) stock prices updated...
 

Immune Design Corp. stock price

Immune Design Corp. latest news:


  • 10/16/2017 14:38:59

    BRIEF-Immune Design gets positive FDA feedback on Phase 3 clinical trial design for CMB305

    Immune Design Corp(IMDZ). * Immune Design(IMDZ) announces positive FDA feedback on Phase 3 clinical trial design for CMB305 in synovial sarcoma patients. * Immune Design (IMDZ)- plans to initiate pivotal Phase 3 trial to support a Biologics License Application for CMB305 in patients with synovial sarcoma‚Äč Source text for Eikon: Further company coverage:

  • More trends:

    Immune Pharmaceuticals Inc.IMNP | ImmunoGen, Inc.IMGN | Immunomedics, Inc.IMMU | Impax Laboratories, Inc.IPXL | Imprimis Pharmaceuticals, Inc.IMMY | INC Research Holdings, Inc.INCR | inContact, Inc.SAAS | Incyte CorporationINCY | Independent Bank Corp.INDB | Independent Bank CorporationIBCP |